<DOC>
	<DOCNO>NCT02729155</DOCNO>
	<brief_summary>This trial 2 x 2 factorial design , double-blinded , randomize control trial evaluate efficacy safety remote ischemic preconditioning postconditioning prevention contrast-induced acute kidney injury patient undergo coronary angiography angioplasty</brief_summary>
	<brief_title>Single-cycle Remote Ischemic Preconditioning Postconditioning Prevention Contrast-Induced Nephropathy ( SCRIP-CIN ) Trial</brief_title>
	<detailed_description />
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Reperfusion Injury</mesh_term>
	<criteria>The patient indication coronary angiography angioplasty . Impaired renal function reduce eGFR &lt; 60 ml/min/1.73 m2 CKDEPI equation . Written informed consent . History contrast allergy . The patient endstage renal failure need hemodialysis . The patient take medication affect kidney function within 48 hour study . The patient acute kidney injury cause . The patient receive contrast medium within 2 week study . The patient cardiac arrest shock . The patient peripheral arterial disease ( PAD ) Pregnancy Refused study</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Ischemic Preconditioning</keyword>
	<keyword>Postconditioning</keyword>
	<keyword>Angioplasty</keyword>
	<keyword>Angiography</keyword>
	<keyword>Contrast-Induced Nephropathy</keyword>
</DOC>